Dr. Gamble is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 Scudders Mill Road
Plainsboro, NJ 08536Phone+1 609-786-4870- Is this information wrong?
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1987
- Oklahoma State University Center for Health SciencesClass of 1982
Certifications & Licensure
- OK State License 1984 - 2023
- AR State License 1983 - 2021
- AOA Board of Internal Medicine Endocrinology
- AOA Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP-4i) in US Adults with Type 2 Diabetes.Tan, X., Liang, Y., Gamble, C., King, A.> ;Diabetes Therapy. 2024 Feb 1
- 1 citationsIncreased Healthcare Resource Use and Costs After Discontinuation of Liraglutide in Patients with Type 2 Diabetes from a Commercial- and Medicaid-Insured Claims Database.Chioma Uzoigwe, Josh Noone, Yuanjie Liang, Sarah Naz Ali, Cory Gamble> ;Diabetes Therapy. 2022 Dec 1
- 2 citationsReal-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospect...Tam Dang-Tan, Pravin Kamble, Yunus Meah, Cory Gamble, Rahul Ganguly, Libby Horter> ;Diabetes Therapy. 2020 Jan 1
- Join now to see all
Professional Memberships
- Member
Industry Relationships
- US Medical Director Victoza, Novo Nordisk Inc2008 - 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: